Correction to: Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner
Ole Heinisch, Thomas Zeyen, Tobias Goldmann, Marco Prinz, Michael Huber, Jennifer Jung, Eren Arik, Shahin Habib, Alexander Slowik, Arno Reich, Jörg B. Schulz, Pardes Habib
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInflammasome and immune disorders · Cholesterol and Lipid Metabolism · Erythropoietin and Anemia Treatment
Correction to: Translational Stroke Research
10.1007/s12975-021-00948-8
We would like to make a clarification in the Authors Contribution. We would like to change “writing” used in the author’s contribution to “correction and editing of revision” to differentiate the various stages of manuscript preparation. We have described “writing” in the actual sense with “preparation of original draft”: OH in the manuscript. The writing actually refers to the final submission after responding to all reviewer comments.
The original article has been corrected.